摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-[4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]-1-oxobutyl]-α,α-dimethylbenzeneacetic acid hydrochloride | 153439-43-1

中文名称
——
中文别名
——
英文名称
4-[4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]-1-oxobutyl]-α,α-dimethylbenzeneacetic acid hydrochloride
英文别名
2-[4-[4-[4-[Hydroxy(diphenyl)methyl]piperidin-1-ium-1-yl]butanoyl]phenyl]-2-methylpropanoic acid;chloride
4-[4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]-1-oxobutyl]-α,α-dimethylbenzeneacetic acid hydrochloride化学式
CAS
153439-43-1
化学式
C32H37NO4*ClH
mdl
——
分子量
536.111
InChiKey
WQPDEFGECAUPKV-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    6.08
  • 重原子数:
    38
  • 可旋转键数:
    10
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.38
  • 拓扑面积:
    77.8
  • 氢给体数:
    3
  • 氢受体数:
    5

反应信息

  • 作为反应物:
    描述:
    参考文献:
    名称:
    Intermediates useful for the preparation of antihistaminic piperidine derivatives
    摘要:
    本发明涉及一种新型中间体和过程,该中间体和过程在制备某些抗组胺酸哌啶衍生物的过程中非常有用,其化学式为 其中 W代表—C(═O)—或—CH(OH)—; R1代表氢或羟基; R2代表氢; R1和R2一起形成连接R1和R2的碳原子之间的第二键; n为1至5的整数; m为0或1的整数; R3为—COOH或—COO烷基,其中烷基基团具有1至6个碳原子,直链或支链,A的每个是氢或羟基;以及其药用可接受盐和各自的光学异构体, 但是当R1和R2一起形成连接R1和R2的碳原子之间的第二键或当R1代表羟基时,m为0。
    公开号:
    US06348597B2
  • 作为产物:
    参考文献:
    名称:
    Intermediates useful for the preparation of antihistaminic piperidine derivatives
    摘要:
    本发明涉及一种新型中间体和过程,该中间体和过程在制备某些抗组胺酸哌啶衍生物的过程中非常有用,其化学式为 其中 W代表—C(═O)—或—CH(OH)—; R1代表氢或羟基; R2代表氢; R1和R2一起形成连接R1和R2的碳原子之间的第二键; n为1至5的整数; m为0或1的整数; R3为—COOH或—COO烷基,其中烷基基团具有1至6个碳原子,直链或支链,A的每个是氢或羟基;以及其药用可接受盐和各自的光学异构体, 但是当R1和R2一起形成连接R1和R2的碳原子之间的第二键或当R1代表羟基时,m为0。
    公开号:
    US06348597B2
点击查看最新优质反应信息

文献信息

  • Intermediates useful for the preparation of antihistaminic piperidine
    申请人:Merrell Pharmaceuticals Inc.
    公开号:US06147216A1
    公开(公告)日:2000-11-14
    The present invention is related to a novel intermediates and processes which are useful in the preparation of certain antihistaminic piperidine derivatives of the formula ##STR1## wherein W represents --C(.dbd.O)-- or --CH(OH)--; R.sub.1 represents hydrogen or hydroxy; R.sub.2 represents hydrogen; R.sub.1 and R.sub.2 taken together form a second bond between the carbon atoms bearing R.sub.1 and R.sub.2 ; n is an integer of from 1 to 5; m is an integer 0 or 1; R.sub.3 is --COOH or --COOalkyl wherein the alkyl moiety has from 1 to 6 carbon atoms and is straight or branched each of A is hydrogen or hydroxy; and pharmaceutically acceptable salts and individual optical isomers thereof, with the proviso that where R.sub.1 and R.sub.2 are ta to form a second bond between the carbon R.sub.1 and R.sub.2 or where R.sub.1 represented hydroxy integer 0.
    本发明涉及一种新型中间体和工艺,可用于制备某些抗组胺酸哌啶衍生物,其化学式为##STR1##其中W代表--C(.dbd.O)--或--CH(OH)--;R.sub.1代表氢或羟基;R.sub.2代表氢;R.sub.1和R.sub.2共同形成连接R.sub.1和R.sub.2的碳原子之间的第二键;n为1至5的整数;m为0或1的整数;R.sub.3为--COOH或--COOalkyl,其中alkyl基含有1至6个碳原子,是直链或支链;每个A都是氢或羟基;以及其药用盐和单体光学异构体,但其中R.sub.1和R.sub.2形成连接R.sub.1和R.sub.2的碳原子之间的第二键或R.sub.1代表羟基时除外。
  • [EN] 4-DIPHENYLMETHYL PIPERIDINE DERIVATIVES AND PROCESS FOR THEIR PREPARATION<br/>[FR] DERIVES DE PIPERIDINE 4-DIPHENYMETHYLIQUE ET LEUR PROCEDE DE PREPARATION
    申请人:MERRELL DOW PHARMACEUTICALS INC.
    公开号:WO1993021156A1
    公开(公告)日:1993-10-28
    (EN) The present invention is related to a novel process for preparing certain piperidine derivatives of formulae (I) and (II) wherein R1 represents hydrogen or hydroxy, R2 represents hydrogen; or R1 and R2 taken together form a second bond between the carbon atoms bearing R1 and R2; n is an integer of from 1 to 5; R3 is -CH2OH, -COOH or -COOalkyl wherein the alkyl moiety has from 1 to 6 carbon atoms and is straight or branched; each of A is hydrogen or hydroxy; and pharmaceutically acceptable salts and individual optical isomers thereof.(FR) L'invention concerne un nouveau procédé de préparation de certains dérivés de pipéridine représentés par les formules (i) et (II) dans lesquelles R1 représente hydrogène ou hydroxy R2 réprésente hydrogène; ou R1 et R2 pris ensemble forment une seconde liaison entre les atomes de carbone portant R1 et R2; n est un entier compris entre 1 et 5; R3 est -CH2OH, -COOHH ou COO alkyle dans lequel la fraction alkyle présente 1 à 6 atomes de carbone et est droite ou ramifiée; chaque A représente hydrogène ou hydroxy; ladite invention concerne également des sels acceptables pharmaceutiquement et des isomères optiques individuels obtenus à partir desdits dérivés.
    该发明涉及一种新型制备某些哌啶衍生物的方法,其化学式为(I)和(II),其中R1代表氢或羟基,R2代表氢;或R1和R2结合形成连接R1和R2的碳原子之间的第二个键;n为1至5的整数;R3为-CH2OH,-COOH或-COOalkyl,其中烷基部分具有1至6个碳原子,并且是直链或支链的;每个A代表氢或羟基;以及其药学上接受的盐和单一光学异构体。
  • Intermediates for the preparation of antihistaminic 4-diphenylmethyl/diphenylmethoxy piperidine derivatives
    申请人:Aventisub II Inc.
    公开号:EP2261208A1
    公开(公告)日:2010-12-15
    The present invention is related to novel intermediates and processes which are useful in the preparation of certain antihistaminic piperidine derivatives of formula (I) wherein W represents -C(=O)- or -CH(OH)-; R1 represents hydrogen or hydroxy; R2 represents hydrogen; R1 and R2 taken together form a second bond between the carbon atoms bearing R1 and R2; n is an integer of from 1 to 5; m is an integer 0 or 1; R3 is -COOH or -COOalkyl wherein the alkyl moiety has from 1 to 6 carbon atoms and is straight or branched; each of A is hydrogen or hydroxy; and pharmaceutically acceptable salts and individual optical isomers thereof, with the proviso that where R1 and R2 are taken together to form a second bond between the carbon atoms bearing R1 and R2 or where R1 represented hydroxy, m is an integer 0.
    本发明涉及一种新型中间体和制备某些抗组胺哌啶衍生物的方法,其化学式为(I),其中W代表-C(=O)-或-CH(OH)-;R1代表氢或羟基;R2代表氢;R1和R2一起形成连接带有R1和R2的碳原子之间的第二个键;n为1至5的整数;m为0或1的整数;R3为-COOH或-COOalkyl,其中烷基具有1至6个碳原子,是直链或支链;每个A是氢或羟基;以及其药学上可接受的盐和单一光学异构体,但当R1和R2一起形成连接带有R1和R2的碳原子之间的第二个键或当R1代表羟基时,m为0。
  • Process for the preparation of antihistaminic 4-diphenylmethyl piperidine derivatives
    申请人:Aventis Inc.
    公开号:EP1953142A1
    公开(公告)日:2008-08-06
    The present invention is related to novel intermediates and processes which are useful in the preparation of certain antihistaminic piperidine derivatives of formula (I) wherein W represents -C(=O)- or -CH(OH)-; R1 represents hydrogen or hydroxy; R2 represents hydrogen; R1 and R2 taken together form a second bond between the carbon atoms bearing R1 and R2; n is an integer of from 1 to 5; m is an integer 0 or 1; R3 is -COOH or -COOalkyl wherein the alkyl moiety has from 1 to 6 carbon atoms and is straight or branched; each of A is hydrogen or hydroxy; and pharmaceutically acceptable salts and individual optical isomers thereof, with the proviso that where R1 and R2 are taken together to form a second bond between the carbon atoms bearing R1 and R2 or where R1 represented hydroxy, m is an integer 0.
    本发明涉及一种新的中间体和过程,可用于制备某些抗组胺哌啶衍生物,该衍生物的化学式为(I),其中W代表-C(=O)-或-CH(OH)-; R1代表氢或羟基; R2代表氢; R1和R2在承载R1和R2的碳原子之间形成第二个键; n是1到5的整数; m是0或1的整数; R3是-COOH或-COOalkyl,其中烷基具有1到6个碳原子,且为直链或支链; A的每个代表氢或羟基; 以及其药学上可接受的盐和单一光学异构体,但其中当R1和R2在承载R1和R2的碳原子之间形成第二个键或R1代表羟基时,m为0。
  • Novel intermediates useful for the preparation of antihistaminic piperidine derivatives
    申请人:Merrell Pharmaceuticals Inc.
    公开号:US20010018521A1
    公开(公告)日:2001-08-30
    The present invention is related to a novel intermediates and processes which are useful in the preparation of certain antihistaminic piperidine derivatives of the formula 1 wherein W represents —C(═O)— or —CH(OH)—; R 1 represents hydrogen or hydroxy; R 2 represents hydrogen; R 1 and R 2 taken together form a second bond between the carbon atoms bearing R 1 and R 2 ; n is an integer of from 1 to 5; m is an integer 0 or 1; R 3 is —COOH or —COOalkyl wherein the alkyl moiety has from 1 to 6 carbon atoms and is straight or branched each of A is hydrogen or hydroxy; and pharmaceutically acceptable salts and individual optical isomers thereof, with the proviso that where R 1 and R 2 are ta′ to form a second bond between the carbon and R 1 and R 2 or where R 1 represented hydroxy integer 0.
    本发明涉及一种新型中间体和过程,其在制备某些抗组胺哌啶衍生物的过程中有用,该衍生物的化学式为1,其中W代表—C(═O)—或—CH(OH)—;R1代表氢或羟基;R2代表氢;R1和R2一起形成连接R1和R2的碳原子之间的第二个键;n为1至5的整数;m为0或1的整数;R3为—COOH或—COO烷基,其中烷基部分具有1至6个碳原子,是直链或支链;每个A都是氢或羟基;以及其药学上可接受的盐和各自的光学异构体,但其中当R1和R2结合形成连接R1和R2的第二个键时,或当R1代表羟基时,n为0。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐